These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28883709)

  • 1. Tegafur-uracil-induced rapid development of advanced hepatic fibrosis.
    Honda S; Sawada K; Hasebe T; Nakajima S; Fujiya M; Okumura T
    World J Gastroenterol; 2017 Aug; 23(31):5823-5828. PubMed ID: 28883709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
    Ikeda K; Kumada H; Arase Y; Chayama K; Gunji T; Yoshiba A; Irimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2411-9. PubMed ID: 2851668
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
    Ishikawa T; Ichida T; Ishimoto Y; Yokoyama J; Nomoto M; Ebe Y; Usuda H; Naito M; Asakura H
    Am J Gastroenterol; 1999 Jun; 94(6):1682-5. PubMed ID: 10364045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
    Kobayashi F; Ikeda T; Sakamoto N; Kurosaki M; Tozuka S; Sakamoto S; Fukuma T; Marumo F; Sato C
    Dig Dis Sci; 1995 Nov; 40(11):2434-7. PubMed ID: 7587827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic liver failure induced by long-term administration of tegafur: a case report.
    Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M
    Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma.
    Ishikawa T; Ichida T; Sugitani S; Tsuboi Y; Genda T; Sugahara S; Uehara K; Inayoshi J; Yokoyama J; Ishimoto Y; Asakura H
    J Gastroenterol Hepatol; 2001 Apr; 16(4):452-9. PubMed ID: 11354285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
    Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2008 May; 14(18):2797-801. PubMed ID: 18473401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
    Miyano M; Kurai O; Hiramatsu S; Yamasaki T; Sasaki E; Adachi K; Oka H
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1139-43. PubMed ID: 20567124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
    Hsu CH; Shen YC; Lin ZZ; Chen PJ; Shao YY; Ding YH; Hsu C; Cheng AL
    J Hepatol; 2010 Jul; 53(1):126-31. PubMed ID: 20416968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
    Ikeda K; Kumada H; Arase Y; Nakamura I; Chayama K; Murashima N; Takeuchi K; Nakajima M; Yoshiba A; Irimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2377-85. PubMed ID: 2830421
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma.
    Nagai H; Matsui T; Kanayama M; Momiyama K; Shizawa K; Wakui N; Shinohara M; Watanabe M; Iida K; Ishii K; Igarashi Y; Sumino Y
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1123-9. PubMed ID: 20180123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
    Zavaglia C; Prisco C; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):87-8. PubMed ID: 18090998
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
    Hsu CY; Shen YC; Yu CW; Hsu C; Hu FC; Hsu CH; Chen BB; Wei SY; Cheng AL; Shih TT
    J Hepatol; 2011 Oct; 55(4):858-65. PubMed ID: 21338641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsy case of multilocular cystic hepatocellular carcinoma without liver cirrhosis.
    Nagano K; Fukuda Y; Nakano I; Katano Y; Toyoda H; Ebata M; Morita K; Yokozaki S; Takeuchi M; Hayashi K; Hayakawa T
    Hepatogastroenterology; 2000; 47(35):1419-21. PubMed ID: 11100365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT].
    Nakanishi T; Nishikawa M; Nagase T; Nakagawa C; Maeda S; Kuroda K; Tokunaga K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2783-6. PubMed ID: 2820315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT].
    Miyagawa H; Kamioka N; Kohara H; Yuube R; Takahashi T; Nakatoh H; Kawada M; Utsunomiya T; Izumiyama F; Akimori T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2211-5. PubMed ID: 8239687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
    Suzuki E; Furuse J; Ikeda M; Ishii H; Okusaka T; Nakachi K; Mitsunaga S; Ueno H; Morizane C
    Jpn J Clin Oncol; 2011 Mar; 41(3):328-33. PubMed ID: 21118849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
    Maruyama T; Nozue M; Aoyagi H; Sakamoto T; Fukue M; Matsui S; Kodaira Y; Monma E; Takada Y; Shidara S; Ikezawa K; Yoshida T; Shimakura S
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):137-41. PubMed ID: 11816471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.